Legislation
- The Liberal, NDP, and Conservative parties say Parliament must assert its jurisdiction over regulating federal parties, as privacy and data advocates urge Senators to pull parts of the ‘privacy-busting bill’ C-4.
- The Liberal, NDP, and Conservative parties say Parliament must assert its jurisdiction over regulating federal parties, as privacy and data advocates urge Senators to pull parts of the ‘privacy-busting bill’ C-4.
- Bill S-240 responds to an October 2025 Supreme Court ruling that mandatory minimums for child sexual abuse material offences violate Sec. 12 of the Charter.
- Bill S-240 responds to an October 2025 Supreme Court ruling that mandatory minimums for child sexual abuse material offences violate Sec. 12 of the Charter.
- The Conservatives have offered avenues for progress on government justice bills and a proposed GST credit, but far too much of the prime minister's agenda is 'still waiting at the starting gate,' says Liberal strategist Joe Jordan.
- The Conservatives have offered avenues for progress on government justice bills and a proposed GST credit, but far too much of the prime minister's agenda is 'still waiting at the starting gate,' says Liberal strategist Joe Jordan.
- Federal ministers and MPs should clearly reaffirm that equity, diversity, and inclusion are integral to public health, research excellence, and professional regulation—not optional political preferences.
- Federal ministers and MPs should clearly reaffirm that equity, diversity, and inclusion are integral to public health, research excellence, and professional regulation—not optional political preferences.
Become a Political Insider
Sign up for Today's Headlines newsletter now
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
- But that doesn’t mean the drug pricing tribunal can’t look at past years’ data to inform future reviews of drug prices, says director general Guillaume Couillard.
- But that doesn’t mean the drug pricing tribunal can’t look at past years’ data to inform future reviews of drug prices, says director general Guillaume Couillard.





































